I am the Chief Financial Officer (CFO) of Innoveren Scientific, Inc, a publicly traded hybrid-biopharmaceutical company dedicated to developing and delivering a novel portfolio of new diagnostics, therapeutics, and medical devices from concept to commercialization. Highly experienced Executive with broad based expertise building and leading effective strategies for financial management, operations management, human resources, information technology, and financial planning and analysis in a variety of industries including healthcare, retail, and hospitality in both the private and public arena. Key participant in negotiation of merger between H-CYTE, INC and RMS Shareholder, LLC, increasing the market cap of the company from $12M to $45M in a four month period. Led the financial strategy in raising over $23M in funding for Innoveren Scientific over a 2-year period using multiple financial instruments including convertible debt, public offerings, and preferred stock. Success in raising over $10M in private equity funding for Regenerative Medicine Solutions over a 6-yer period to help with executing growth strategy.A demonstrated record of success establishing relationships and motivating teams to produce consistent results in a rapidly changing environment. Responsible for all aspects of financial operations of both private and public companies including long range strategic planning, annual budgeting, policy and system implementation, internal financial controls, external audits, and SEC reporting.CORE COMPETENCIES  Debt and Equity Capital Acquisition SEC Public Company Reporting  Budgets and Forecasting Develop and Improve GAAP Accounting Systems Operational Systems Development Mergers and Acquisitions Financial and Operational Modeling Business Plan Development and Execution Financial Control Management Strong Problem Solving and Analytical CapabilitiesLeads the Accounting, Human Resources, and Information Technology departments for a publicly held company. Developed and maintains all financial and accounting systems in accordance with GAAP. Works directly with auditors, SEC counsel, and audit committee chair to ensure all financial reporting is accurate and proper controls and systems are in place to ensure reporting consistency and comparability for public market. Responsible for all SEC filings including preparing and reviewing the 10-K, 10-Q, 8-Ks, and Registration Statements for public offerings.